BIOMAT Database Logo BIOMAT Database Logo

Recurrence of ANCA-positive glomerulonephritis immediately after renal transplantation. 2003

Thierry Lobbedez, and François Comoz, and Eric Renaudineau, and Myriam Pujo, and Jean-Philippe Ryckelynck, and Bruno Hurault de Ligny
Nephrology and Pathology Department, Caen University Hospital, Caen, France. lobbedez-t@chu-caen.fr

Recurrence of crescentic necrotizing glomerulonephritis after renal transplantation is rare. Successful renal transplantation in patients with antineutrophil cytoplasmic autoantibody (ANCA) glomerulonephritis has been reported. The presence of ANCA at transplantation does not appear to increase the rate of relapse after kidney allografting. Therapy with cyclophosphamide and corticoids usually is effective. We report a case of recurrent perinuclear ANCA crescentic necrotizing glomerulonephritis immediately after renal transplantation that was treated successfully by cyclophosphamide, plasma exchange, and intravenous polyvalent immunoglobulin.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D005921 Glomerulonephritis Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY. Bright Disease,Kidney Scarring,Glomerulonephritides,Scarring, Kidney
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D016030 Kidney Transplantation The transference of a kidney from one human or animal to another. Grafting, Kidney,Renal Transplantation,Transplantation, Kidney,Transplantation, Renal,Kidney Grafting,Kidney Transplantations,Renal Transplantations,Transplantations, Kidney,Transplantations, Renal
D016756 Immunoglobulins, Intravenous Immunoglobulin preparations used in intravenous infusion, containing primarily IMMUNOGLOBULIN G. They are used to treat a variety of diseases associated with decreased or abnormal immunoglobulin levels including pediatric AIDS; primary HYPERGAMMAGLOBULINEMIA; SCID; CYTOMEGALOVIRUS infections in transplant recipients, LYMPHOCYTIC LEUKEMIA, CHRONIC; Kawasaki syndrome, infection in neonates, and IDIOPATHIC THROMBOCYTOPENIC PURPURA. Antibodies, Intravenous,Human Intravenous Immunoglobulin,IV Immunoglobulin,IVIG,Intravenous Antibodies,Intravenous Immunoglobulin,Intravenous Immunoglobulins,Alphaglobin,Endobulin,Flebogamma DIF,Gamimmune,Gamimmune N,Gamimune,Gamimune N,Gammagard,Gammonativ,Gamunex,Globulin-N,IV Immunoglobulins,Immune Globulin Intravenous (Human),Immune Globulin, Intravenous,Immunoglobulins, Intravenous, Human,Intraglobin,Intraglobin F,Intravenous IG,Intravenous Immunoglobulins, Human,Iveegam,Modified Immune Globulin (Anti-Echovirus Antibody),Privigen,Sandoglobulin,Venimmune,Venoglobulin,Venoglobulin-I,Globulin N,Human Intravenous Immunoglobulins,Immunoglobulin, Human Intravenous,Immunoglobulin, IV,Immunoglobulin, Intravenous,Immunoglobulins, Human Intravenous,Immunoglobulins, IV,Intravenous Immune Globulin,Intravenous Immunoglobulin, Human,Venoglobulin I

Related Publications

Thierry Lobbedez, and François Comoz, and Eric Renaudineau, and Myriam Pujo, and Jean-Philippe Ryckelynck, and Bruno Hurault de Ligny
Early and irreversible recurrence MPO-ANCA-positive glomerulonephritis after renal transplantation.
June 2015, Clinical nephrology,
Thierry Lobbedez, and François Comoz, and Eric Renaudineau, and Myriam Pujo, and Jean-Philippe Ryckelynck, and Bruno Hurault de Ligny
Recurrence of glomerulonephritis after renal transplantation.
October 2013, Transplantation reviews (Orlando, Fla.),
Thierry Lobbedez, and François Comoz, and Eric Renaudineau, and Myriam Pujo, and Jean-Philippe Ryckelynck, and Bruno Hurault de Ligny
[Rapid recurrence of ANCA-MPO positive vasculitis after non-heart beating donor renal transplantation].
January 2006, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia,
Thierry Lobbedez, and François Comoz, and Eric Renaudineau, and Myriam Pujo, and Jean-Philippe Ryckelynck, and Bruno Hurault de Ligny
Renal transplantation of ANCA-positive idiopathic crescentic glomerulonephritis: two-year follow-up.
September 1994, Clinical nephrology,
Thierry Lobbedez, and François Comoz, and Eric Renaudineau, and Myriam Pujo, and Jean-Philippe Ryckelynck, and Bruno Hurault de Ligny
ANCA-positive glomerulonephritis.
May 1992, Journal of the Tennessee Medical Association,
Thierry Lobbedez, and François Comoz, and Eric Renaudineau, and Myriam Pujo, and Jean-Philippe Ryckelynck, and Bruno Hurault de Ligny
Recurrence of type III membranoproliferative glomerulonephritis after renal transplantation.
January 2004, Clinical nephrology,
Thierry Lobbedez, and François Comoz, and Eric Renaudineau, and Myriam Pujo, and Jean-Philippe Ryckelynck, and Bruno Hurault de Ligny
[ANCA-positive necrotizing glomerulonephritis].
January 1997, Ryoikibetsu shokogun shirizu,
Thierry Lobbedez, and François Comoz, and Eric Renaudineau, and Myriam Pujo, and Jean-Philippe Ryckelynck, and Bruno Hurault de Ligny
Recurrence of membranoproliferative glomerulonephritis after renal transplantation in Denys-Drash.
February 2011, Pediatric nephrology (Berlin, Germany),
Thierry Lobbedez, and François Comoz, and Eric Renaudineau, and Myriam Pujo, and Jean-Philippe Ryckelynck, and Bruno Hurault de Ligny
Rapid recurrence of ANCA-negative pauci-immune vasculitis after cadaveric renal transplantation.
July 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation,
Thierry Lobbedez, and François Comoz, and Eric Renaudineau, and Myriam Pujo, and Jean-Philippe Ryckelynck, and Bruno Hurault de Ligny
Recurrence of ANCA-negative renal-limited pauci-immune glomerulonephritis in the renal allograft.
October 2013, Clinical kidney journal,
Copied contents to your clipboard!